Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 361 AL 375

CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 May 4;24(9):8230. doi: 10.3390/ijms24098230.

Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets

Song M, Fan X.

Int J Mol Sci. 2023 May 7;24(9):8398. doi: 10.3390/ijms24098398.

Functions of Astrocytes under Normal Conditions and after a Brain Disease

Valles SL, Singh SK, Campos-Campos J, Colmena C, Campo-Palacio I, Alvarez-Gamez K, Caballero O, Jorda A.

Int J Mol Sci. 2023 May 8;24(9):8434. doi: 10.3390/ijms24098434.

Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease

Zhang M, Yu M, Guo R, Zhang Y, Zhang X, Sun J, Zhang J, Wang X, Ma J.

Stem Cell Res. 2023 Jun;69:103116. doi: 10.1016/j.scr.2023.103116. Epub 2023 May 6.

Meta-Analysis of Variations in Association between APOE ɛ4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin

Huggins LKL, Min SH, Kaplan S, Wei J, Welsh-Bohmer K, Xu H.

J Alzheimers Dis. 2023;93(3):1095-1109. doi: 10.3233/JAD-221167.

Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease

Li Y, Chang J, Chen X, Liu J, Zhao L.

J Alzheimers Dis. 2023;93(4):1195-1210. doi: 10.3233/JAD-230179.

BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study

Cognat E, Sabia S, Fayel A, Lilamand M, Handels R, Fascendini S, Bergh S, Frisoni GB, Fabbo A, Tsolaki M, Frölich L, Peters O, Merlo P, Ciccone A, Mecocci P, Dumurgier J, Defanti CA, Hugon J, Paquet C.

Am J Geriatr Psychiatry. 2023 Aug;31(8):633-639. doi: 10.1016/j.jagp.2023.03.014. Epub 2023 Apr 23.

The amyloid cascade hypothesis: an updated critical review

Kepp KP, Robakis NK, Høilund-Carlsen PF, Sensi SL, Vissel B.

Brain. 2023 Oct 3;146(10):3969-3990. doi: 10.1093/brain/awad159.

Designing multi-target drugs for the treatment of major depressive disorder

Halder AK, Mitra S, Cordeiro MNDS.

Expert Opin Drug Discov. 2023 Jun;18(6):643-658. doi: 10.1080/17460441.2023.2214361. Epub 2023 May 19.

Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues

Kumari S, Dhapola R, Reddy DH.

Apoptosis. 2023 Aug;28(7-8):943-957. doi: 10.1007/s10495-023-01848-y. Epub 2023 Apr 26.

Role of de novo lipogenesis in inflammation and insulin resistance in Alzheimer's disease

Khan MA, Khan ZA, Shoeb F, Fatima G, Khan RH, Khan MM.

Int J Biol Macromol. 2023 Jul 1;242(Pt 2):124859. doi: 10.1016/j.ijbiomac.2023.124859. Epub 2023 May 13.

Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man

Lopera F, Marino C, Chandrahas AS, O'Hare M, Villalba-Moreno ND, Aguillon D, Baena A, Sanchez JS, Vila-Castelar C, Ramirez Gomez L, Chmielewska N, Oliveira GM, Littau JL, Hartmann K, Park K, Krasemann S, Glatzel M, Schoemaker D, Gonzalez-Buendia L, Delgado-Tirado S, Arevalo-Alquichire S, Saez-Torres KL, Amarnani D, Kim LA, Mazzarino RC, Gordon H, Bocanegra Y, Villegas A, Gai X, Bootwalla M, Ji J, Shen L, Kosik KS, Su Y, Chen Y, Schultz A, Sperling RA, Johnson K, Reiman EM, Sepulveda-Falla D, Arboleda-Velasquez JF, Quiroz YT.

Nat Med. 2023 May;29(5):1243-1252. doi: 10.1038/s41591-023-02318-3. Epub 2023 May 15.

The Functions and Phenotypes of Microglia in Alzheimer's Disease

Fujikawa R, Tsuda M.

Cells. 2023 Apr 21;12(8):1207. doi: 10.3390/cells12081207.

[Anti-Dementia Drugs (Anti-Alzheimer's Disease Drugs)]

Yamada M.

Brain Nerve. 2023 May;75(5):464-469. doi: 10.11477/mf.1416202360.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias